CD24 and neoplasm: To transport anti-CD24 mAb (aCD24), celastrol (CEL), and mitofusin 1 shRNA (shMFN1) for synergistic tumor cell-targeted therapy and TAM-targeted immunomodulation, engineering nanoparticles were created [31, 33, 51].